Newsroom
Sorted by: Latest
-
Coherent Solutions chiude un investimento strategico condotto da IceLake
MINNEAPOLIS e AMSTERDAM--(BUSINESS WIRE)--Coherent Solutions, azienda globale di ingegneria digitale, ha annunciato la chiusura del suo investimento strategico da parte di IceLake, uno dei maggiori investitori di private equity specializzato in collaborazioni con organizzazioni di servizi aziendali ad alta crescita. La transazione, già annunciata nel settembre 2025, ha ora ottenuto tutte le necessarie autorizzazioni regolatorie. Coherent Solutions impiega circa 2.000 professionisti nei settori...
-
Stacy Scholtz Named Chief Operating Officer at Mutual of Omaha
OMAHA, Neb.--(BUSINESS WIRE)--Stacy Scholtz has been named Chief Operating Officer at Mutual of Omaha, according to Chairman and CEO James Blackledge. Scholtz, who joined Mutual of Omaha in 1991, has held a variety of executive positions at the insurance and financial services company, including Executive Vice President of Corporate Operations. She most recently served as Executive Vice President of Financial Solutions, leading the Income and Wealth Planning Solutions and Emerging and Strategic...
-
Report From FINRA Board of Governors Meeting – December 2025
WASHINGTON--(BUSINESS WIRE)--FINRA’s Board of Governors held its final meeting of the year Dec. 10-11. The Board approved three rule proposals. It also reviewed FINRA’s 2025 financial performance and approved FINRA’s 2026 budget. More information about FINRA's finances will be provided in FINRA’s annual financial report and budget summary. Rulemaking The three rule proposals reflect feedback FINRA has received on the rule modernization effort that is part of FINRA Forward, a series of initiativ...
-
SLM Investors Have Opportunity to Lead SLM Corporation a/k/a Sallie Mae Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--SLM Investors Have Opportunity to Lead SLM Corporation a/k/a Sallie Mae Securities Fraud Lawsuit with the Schall Law Firm...
-
FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm...
-
Money Transfer Apps Market Worth $52 Billion by 2030: Market-Entry and Growth Strategies Through 2026-2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Money Transfer App Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Money Transfer App was valued at US$22.5 Billion in 2024 and is projected to reach US$52 Billion by 2030, growing at a CAGR of 15% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Growth in the money transfer app marke...
-
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This act...
-
Incyte Japan gibt die Zulassung von Minjuvi® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid zur Behandlung von rezidiviertem oder refraktärem follikulärem Lymphom bekannt
TOKIO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. gab heute bekannt, dass das japanische Ministerium für Gesundheit, Arbeit und Soziales (MHLW) Minjuvi® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid für erwachsene Patienten mit rezidiviertem oder refraktärem follikulärem Lymphom (2L+ FL) zugelassen hat. „Die heutige Zulassung von Minjuvi in Kombination mit Rituximab und Lenalidomid ist ein bedeutender Meilenstein, da es sich um die erste dual-zielgerichtete CD19- und CD20-Immun...
-
FloWorks Acquires Cranford Equipment Company
ROSEMONT, Ill.--(BUSINESS WIRE)--FloWorks International LLC (“FloWorks”), a leading specialty distributor of critical flow control products and a portfolio company of Wynnchurch Capital, L.P. (“Wynnchurch”), today announced the acquisition of Cranford Equipment Co., Inc. (“CEC” or the “Company”). Headquartered in Kenner, Louisiana, CEC is a distributor of filtration products, serving diverse industrial applications. Scott Jackson, CEO of FloWorks, commented on the transaction, saying, “Bart and...
-
El Un-carrier y su Un-wrapped de 2025
BELLEVUE, Wash.--(BUSINESS WIRE)--Un año tan increíble para T-Mobile que se merece un ¡salud! por todo lo que El Un-carrier ha logrado en el 2025. La compañía se convirtió oficialmente en la Mejor Red del País y alcanzó su trimestre más fuerte en más de una década. Fast Company reconoció que la cultura de T-Mobile desafía el status quo y nos incluyó en su lista de Los mejores entornos laborales para innovadores. La versión beta del servicio directo a celular de T-Satellite con Starlink debutó y...